Evidence mapPaperPMID 35659255Full record

ArticleFluids and barriers of the CNS2022

Glioblastoma microenvironment contains multiple hormonal and non-hormonal growth-stimulating factors.

Daniel Dahlberg, Jutta Rummel, Sonia Distante, Gustavo Antonio De Souza, Maria Ekman Stensland, Espen Mariussen, Helge Rootwelt, Øyvind Voie, Bjørnar Hassel

Abstract read
In one paragraph

Article in Fluids and barriers of the CNS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Observational
  2. Review
  3. Article
  4. Article
  5. Tumors and their microenvironments: Learning from pediatric brain pathologies.Biochimica et biophysica acta. Reviews on cancer · 2025
    Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Liquid biomarkers in glioma.Brain tumor pathology · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daniel DahlbergDepartment of Neurosurgery, Oslo University Hospital, Nydalen, PO box 4950, 0424, Oslo, Norway. dandah@ous-hf.no.
Jutta RummelDepartment of Neurohabilitation and Complex Neurology, Oslo University Hospital, Oslo, Norway.
Sonia DistanteDepartment of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Gustavo Antonio De SouzaInstitute of Immunology and Centre for Immune Regulation, Oslo University Hospital, Oslo, Norway.
Maria Ekman StenslandInstitute of Immunology and Centre for Immune Regulation, Oslo University Hospital, Oslo, Norway.
Espen MariussenNorwegian Defence Research Establishment (FFI), Kjeller, Norway.
Helge RootweltDepartment of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.
Øyvind VoieNorwegian Defence Research Establishment (FFI), Kjeller, Norway.
Bjørnar HasselDepartment of Neurohabilitation and Complex Neurology, Oslo University Hospital, Oslo, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe growth of malignant tumors is influenced by their microenvironment. Glioblastoma, an aggressive primary brain tumor, may have cysts containing fluid that represents the tumor microenvironment. The aim of this study was to investigate whether the cyst fluid of cystic glioblastomas contains growth-stimulating factors. Identification of such growth factors may pave the way for the development of targeted anti-glioblastoma therapies.

methodsWe performed hormone analysis of cyst fluid from 25 cystic glioblastomas and proteomics analysis of cyst fluid from another 12 cystic glioblastomas.

resultsGlioblastoma cyst fluid contained hormones within wide concentration ranges: Insulin-like growth factor 1 (0-13.7 nmol/L), insulin (1.4-133 pmol/L), erythropoietin (4.7-402 IU/L), growth hormone (0-0.93 µg/L), testosterone (0.2-10.1 nmol/L), estradiol (0-1.0 nmol/L), triiodothyronine (1.0-11.5). Tumor volume correlated with cyst fluid concentrations of growth hormone and testosterone. Survival correlated inversely with cyst fluid concentration of erythropoietin. Several hormones were present at concentrations that have been shown to stimulate glioblastoma growth in vitro. Concentrations of erythropoietin and estradiol (in men) were higher in cyst fluid than in serum, suggesting formation by tumor or brain tissue. Quantitatively, glioblastoma cyst fluid was dominated by serum proteins, illustrating blood-brain barrier leakage. Proteomics identified several proteins that stimulate tumor cell proliferation and invasiveness, others that inhibit apoptosis or mediate adaption to hypoxia and some that induce neovascularization or blood-brain barrier leakage.

conclusionThe microenvironment of glioblastomas is rich in growth-stimulating factors that may originate from the circulation, the tumor, or the brain. The wide variation in cyst fluid hormone concentrations may differentially influence tumor growth.

Indexed as

ErythropoietinGlioblastomaEstradiolGrowth HormoneHumansMaleTestosteroneTumor MicroenvironmentErythropoietinEstradiolGrowth HormoneTestosteroneCyst fluidErythropoietinGlioblastomaGrowth factorsInsulin-like growth factorTestosterone

Identifiers

PMID35659255
PMCPMC9166426

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.